A Two-part, Randomised, Placebo-controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamicsof Single and Repeat Doses of Intravenously Infused GSK1995057 in Healthy Subjects
Latest Information Update: 06 Sep 2023
At a glance
- Drugs GSK 1995057 (Primary)
- Indications Acute lung injury; Adult respiratory distress syndrome
- Focus Adverse reactions
- Sponsors GSK
Most Recent Events
- 16 Apr 2014 New trial record